Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coiled-coil domain-containing protein 3 (CCDC3) is a secreted protein characterized by coiled-coil motifs, acting primarily as a regulatory factor in various cellular signaling networks. It is involved in protein-protein interactions, organization of cell structure, and important signal transduction pathways[1][2]. CCDC3 inhibits TNF-alpha-induced pro-inflammatory responses in endothelial cells by blocking NF-κB activation[2][6], and it modulates lipid metabolism by repressing inflammatory signaling and positively regulating lipid accumulation in adipose cells[2][7]. Aberrant regulation of CCDC3 has been implicated in cancer biology (by suppressing breast cancer growth through p53 stabilization[5]), metabolic disorders, and cardiovascular disease, suggesting a role as a disease biomarker and a potential (though not established) therapeutic target[1][2][5]. While not a classical receptor, enzyme, or transporter, CCDC3 is of marked interest as a secretory regulatory molecule in multiple disease contexts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coiled-coil domain-containing protein 3 (CCDC3).